<i>Trichomonas vaginalis</i> Among Cisgender Women Taking Doxycycline Postexposure Prophylaxis

Doxycycline treats and prevents several bacterial and parasitic infections and has been proposed as a possible treatment for Trichomonas vaginalis. Nested in a trial of doxycycline postexposure prophylaxis among cisgender women in Kenya, we conducted a secondary analysis of incident T. vaginalis infections. Among 224 cisgender women randomized to doxycycline postexposure prophylaxis and 225 to standard-of-care, there were 27 T. vaginalis diagnoses in the doxycycline postexposure prophylaxis group and 29 in the standard-of-care group (RR: 0.96, 95% CI: 0.54-1.73, P = .9). Understanding doxycycline postexposure prophylaxis's impact on T. vaginalis remains an important public health question that warrants further investigation.

Authors

Institutions

Publication Details

Journal
The Journal of Infectious Diseases
Published
2025-10-08
DOI
https://doi.org/10.1093/infdis/jiaf519
Primary Topic
Reproductive tract infections research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trichomonas vaginalis Among Cisgender Women Taking Doxycycline Postexposure Prophylaxis

Lauren R. Violette, Jenell Stewart, Elizabeth A. Bukusi, R. Scott McClelland et al.
The Journal of Infectious Diseases
Reproductive tract infections research
article

Trichomonas vaginalis Among Cisgender Women Taking Doxycycline Postexposure Prophylaxis

Lauren R. Violette, Jenell Stewart, Elizabeth A. Bukusi, R. Scott McClelland, Felix Mogaka, Jared M. Baeten, Deborah Donnell, Fredericka A. Sesay, Kevin Oware, Josephine Odoyo, JE Balkus, Victor Omollo
article en

Abstract

Doxycycline treats and prevents several bacterial and parasitic infections and has been proposed as a possible treatment for Trichomonas vaginalis. Nested in a trial of doxycycline postexposure prophylaxis among cisgender women in Kenya, we conducted a secondary analysis of incident T. vaginalis infections. Among 224 cisgender women randomized to doxycycline postexposure prophylaxis and 225 to standard-of-care, there were 27 T. vaginalis diagnoses in the doxycycline postexposure prophylaxis group and 29 in the standard-of-care group (RR: 0.96, 95% CI: 0.54-1.73, P = .9). Understanding doxycycline postexposure prophylaxis's impact on T. vaginalis remains an important public health question that warrants further investigation.

The Journal of Infectious DiseasesVol. 233(2)
University of Minnesota (US), Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA), Infectious Disease Research Institute (US), Public Health – Seattle & King County (US), Harvard University (US), University of Washington (US), University of Minnesota System (US), Kenya Medical Research Institute (KE), Fred Hutch Cancer Center (US), Harvard Pilgrim Health Care (US), Hennepin Healthcare Research Institute (US), Seattle University (US)
Openalex Percentile: Top 74%
Reproductive tract infections research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.